Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fourrts Laboratories (Fourrts (India) Laboratories Private Limited) is a rapidly growing pharmaceutical company headquartered in Chennai, India. Founded in 1977, the company specializes in the development, manufacturing, and marketing of a diverse range of branded generic formulations, nutraceuticals, and herbo-mineral products. Fourrts is a pioneer in the Indian nutraceutical market, with leading brands such as Fourts B (multivitamins), Rejunuron (neuropathy management), and Sucrafil (gastrointestinal care). The company operates state-of-the-art manufacturing facilities, including a WHO-GMP certified plant and a world-class facility approved by major global regulatory bodies such as the US FDA, UK MHRA, EU GMP, and Health Canada. Fourrts serves both domestic and international markets, exporting its products to over 50 countries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fourrts Laboratories.